Developer docs
API playgroundTry for free, no card

Search company profiles

Bright Way Group

Full company profile

uuid0041yzu

Namestring
Bright Way Group
Legal namestring
ООО «Велфарм»
Websiteurl
brway.ru
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Velpharm Group (Bright Way Group) is a Russian pharmaceutical manufacturing company that develops, produces, and distributes generic medications and vital essential medicines for the Russian domestic market. The group operates through a multi-subsidiary structure: ООО «Велфарм» (Velpharm) serves as the parent company, Velpharm-M operates manufacturing facilities including a new plant opened in Zelenograd in October 2022, Veltrade handles trading and distribution, Velpharm MC functions as the management company, and Velpharm Global (operating under the Biomialvel brand) pursues international operations. Production is based at two sites in Kurgan and Zelenograd, with plans announced in September 2022 for a world-class pharmaceutical cluster in Zelenograd.

The company's product portfolio includes 12+ marketed preparations, 23+ vital essential medicines, 43+ preparations in registration, and 27+ in development, concentrated in one core therapeutic area. The group offers contract manufacturing, licensing production, and private label (СТМ) programs for pharmacy chains, alongside direct supply to hospitals, clinics, and medical facilities. Technical capabilities center on modern pharmaceutical manufacturing technologies rather than digital or AI-driven differentiation.

Velpharm generates revenue primarily through one-time B2B pharmaceutical product sales contracts with pharmacy chains, healthcare institutions, and distributors across Russia. The go-to-market motion is enterprise field sales targeting pharmacy networks and institutional buyers. The company's strategy is explicitly aligned with the Russian Federation's national pharmaceutical policy objective to increase domestic production share to 50% by 2030, and it was recognized as a 2025 laureate of the Government Prize of the Russian Federation in the Field of Quality, reinforcing its position as a favored domestic manufacturer under the import substitution framework.

Short descriptiontext

Velpharm Group (Bright Way Group) is a Russian pharmaceutical manufacturer producing generic and vital essential medicines for pharmacy chains and healthcare institutions, operating manufacturing facilities in Kurgan and Zelenograd with private label and contract manufacturing services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMoscow, Russia
HQ citystring
Moscow
HQ countrystring
Russia
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical manufacturing, drug production, contract manufacturing, essential medicines, private label pharma
Industry2 codes
PRIMARYHLAIAAAA
Primary Care & General Medicine Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAGAHAL
GMP Scale-Up, Tech Transfer & Process Validation (PPQ)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Pharmaceutical and Medicine Manufacturing3254
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Pharmaceutical Manufacturing
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Drug Sales
TypeOne Time License
Description

Revenue generated from manufacturing and selling pharmaceutical preparations to pharmacy chains, healthcare institutions, and distributors. Product portfolio includes 12+ preparations, 23+ vital essential medicines, 43+ preparations in registration phase, and 27+ in development.

velpharm.group
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Velpharm Group is a Russian pharmaceutical manufacturing company that produces modern, high-quality, and affordable medicinal products, including essential medicines, with a portfolio of 12+ marketed preparations, 23+ vital essential medicines, 43+ preparations in registration, and 27+ under development. Beyond its own branded pharmaceutical production, the group offers contract manufacturing, licensing production, and private label (СТМ) projects for pharmacy chains, operating production facilities in Kurgan and at the newly opened Velpharm-M plant.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Velpharm Group (Велфарм Группа) is a Russian pharmaceutical manufacturing company comprising multiple subsidiaries: Velpharm (parent company focused on drug production and development), Velpharm-M (manufacturing facility with a new plant opened in 2022 in Zelenograd), Veltrade (distribution/trade subsidiary), Velpharm MC (management company), and Velpharm Global/Biomialvel (international operations subsidiary). The group operates production facilities in Kurgan and Zelenograd, producing pharmaceutical medications including essential drugs, with a strategic goal to increase domestic production share to 50% by 2030. The company also offers contract manufacturing, licensing production, and private label (STM) projects for pharmacy chains.

Product and service4 records
1Pharmaceutical Product Portfolio
CategoryPharmaceutical products
Description

Branded portfolio of pharmaceutical preparations including 12+ marketed medications and 23+ vital essential medicines, sold to pharmacy chains, healthcare institutions, and distributors across Russia.

2Contract Manufacturing Services
CategoryManufacturing services
Description

B2B contract and license manufacturing of pharmaceutical products using the group's production facilities, offered to pharmaceutical partners.

3Private Label (СТМ) Production for Pharmacy Chains
CategoryManufacturing services
Description

Private label (СТМ) manufacturing projects implemented for retail pharmacy chains, enabling pharmacy networks to offer their own branded pharmaceutical preparations produced by Velpharm Group.

4Velpharm-M Manufacturing Plant (Zelenograd)
CategoryManufacturing facility
Description

Newly opened pharmaceutical production plant 'Велфарм•М' (Velpharm-M) operating as the group's manufacturing subsidiary for the production of medicinal products.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Velpharm Group implements private label (СТМ) projects for pharmacy chains, offering contract manufacturing and licensing production services. This enables pharmacy networks to offer their own branded pharmaceutical products manufactured by Velpharm.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Major Russian pharmaceutical manufacturer with branded generics, hospital, and contract manufacturing operations. Directly comparable to Velpharm in product category, B2B channels, and alignment with state domestic production policies.

TypeDirect peer
Description

Russian finished-dose pharmaceutical manufacturer serving pharmacy chains and hospitals with a broad generic portfolio. Directly comparable to Velpharm's manufacturing model and domestic-market focus.

TypeDirect peer
Description

Russian biopharmaceutical company producing both biologics and small-molecule generics with significant government backing. Comparable to Velpharm as a domestic manufacturer aligned with Russian pharmaceutical sovereignty goals.

TypeBroad incumbent
Description

European generic pharmaceutical manufacturer with strong Eastern European and CIS market presence. Comparable to Velpharm in generic finished-dose manufacturing and in competing for CIS/Russian pharmacy chain demand.

TypeBroad incumbent
Description

Global leader in generic pharmaceuticals with broad finished-dose manufacturing capabilities. Comparable to Velpharm at a category level (generic finished-dose manufacturing), though operating at vastly greater scale and global geography.

TypeDirect peer
Description

Russian pharmaceutical company producing finished-dose generics and biologics with strong domestic market presence. Comparable to Velpharm as a domestic finished-dose manufacturer with government-aligned priorities.

TypeDirect peer
Description

Russian pharmaceutical manufacturer with a broad branded generic and OTC portfolio sold primarily through pharmacy chains. Directly comparable to Velpharm in target customer base and finished-dose offering.

TypeDirect peer
Description

One of Russia's largest pharmaceutical manufacturers producing branded and generic preparations for primary care and hospital use. Directly comparable to Velpharm as a domestic finished-dose manufacturer targeting the same pharmacy chains and state-aligned import substitution agenda.

9Obnovlenie (Renewal)
TypeDirect peer
Description

Russian generic pharmaceutical manufacturer with a large SKU catalog distributed via pharmacy chains. Directly comparable to Velpharm in product type, scale, and reliance on the domestic pharmacy retail channel.

10Polysan
TypeDirect peer
Description

Russian pharmaceutical manufacturer of branded generics and original products sold through pharmacy chains. Directly comparable to Velpharm in product category and B2B pharmacy channel.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bright Way Group

Pharmaceutical Manufacturingbrway.ru

Velpharm Group (Bright Way Group) is a Russian pharmaceutical manufacturer producing generic and vital essential medicines for pharmacy chains and healthcare institutions, operating manufacturing facilities in Kurgan and Zelenograd with private label and contract manufacturing services.

What Bright Way Group does

Velpharm Group (Bright Way Group) is a Russian pharmaceutical manufacturing company that develops, produces, and distributes generic medications and vital essential medicines for the Russian domestic market. The group operates through a multi-subsidiary structure: ООО «Велфарм» (Velpharm) serves as the parent company, Velpharm-M operates manufacturing facilities including a new plant opened in Zelenograd in October 2022, Veltrade handles trading and distribution, Velpharm MC functions as the management company, and Velpharm Global (operating under the Biomialvel brand) pursues international operations. Production is based at two sites in Kurgan and Zelenograd, with plans announced in September 2022 for a world-class pharmaceutical cluster in Zelenograd.

The company's product portfolio includes 12+ marketed preparations, 23+ vital essential medicines, 43+ preparations in registration, and 27+ in development, concentrated in one core therapeutic area. The group offers contract manufacturing, licensing production, and private label (СТМ) programs for pharmacy chains, alongside direct supply to hospitals, clinics, and medical facilities. Technical capabilities center on modern pharmaceutical manufacturing technologies rather than digital or AI-driven differentiation.

Velpharm generates revenue primarily through one-time B2B pharmaceutical product sales contracts with pharmacy chains, healthcare institutions, and distributors across Russia. The go-to-market motion is enterprise field sales targeting pharmacy networks and institutional buyers. The company's strategy is explicitly aligned with the Russian Federation's national pharmaceutical policy objective to increase domestic production share to 50% by 2030, and it was recognized as a 2025 laureate of the Government Prize of the Russian Federation in the Field of Quality, reinforcing its position as a favored domestic manufacturer under the import substitution framework.

Bright Way Group firmographics

Firmographics
Name
Bright Way Group
Legal name
ООО «Велфарм»
Website
https://brway.ru
Company type
Private
Operating status
Operating
Headcount range
11–50 employees
Short description
Velpharm Group (Bright Way Group) is a Russian pharmaceutical manufacturer producing generic and vital essential medicines for pharmacy chains and healthcare institutions, operating manufacturing facilities in Kurgan and Zelenograd with private label and contract manufacturing services.
Ownership category
akta.pro rank

Bright Way Group industry classification

Industry
Product category
Pharmaceutical Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIAAAA
Primary Care & General Medicine Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAGAHAL
GMP Scale-Up, Tech Transfer & Process Validation (PPQ)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services

Keywords

  • Pharmaceutical manufacturing
  • Drug production
  • Contract manufacturing
  • Essential medicines
  • Private label pharma

Where Bright Way Group is headquartered

Location

Headquarters

HQ city
Moscow
HQ country
Russia
HQ region
Europe

Offices3 records

Markets served

Bright Way Group business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure

Revenue model

  1. Pharmaceutical Drug Sales: Revenue generated from manufacturing and selling pharmaceutical preparations to pharmacy chains, healthcare institutions, and distributors. Product portfolio includes 12+ preparations, 23+ vital essential medicines, 43+ preparations in registration phase, and 27+ in development.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Bright Way Group product offering

Product offering

Core offering

Velpharm Group is a Russian pharmaceutical manufacturing company that produces modern, high-quality, and affordable medicinal products, including essential medicines, with a portfolio of 12+ marketed preparations, 23+ vital essential medicines, 43+ preparations in registration, and 27+ under development. Beyond its own branded pharmaceutical production, the group offers contract manufacturing, licensing production, and private label (СТМ) projects for pharmacy chains, operating production facilities in Kurgan and at the newly opened Velpharm-M plant.

Product overview

Velpharm Group (Велфарм Группа) is a Russian pharmaceutical manufacturing company comprising multiple subsidiaries: Velpharm (parent company focused on drug production and development), Velpharm-M (manufacturing facility with a new plant opened in 2022 in Zelenograd), Veltrade (distribution/trade subsidiary), Velpharm MC (management company), and Velpharm Global/Biomialvel (international operations subsidiary). The group operates production facilities in Kurgan and Zelenograd, producing pharmaceutical medications including essential drugs, with a strategic goal to increase domestic production share to 50% by 2030. The company also offers contract manufacturing, licensing production, and private label (STM) projects for pharmacy chains.

Differentiator

Problem solved

Functional benefit

Products and services

  • Pharmaceutical Product Portfolio Branded portfolio of pharmaceutical preparations including 12+ marketed medications and 23+ vital essential medicines, sold to pharmacy chains, healthcare institutions, and distributors across Russia.
  • Contract Manufacturing Services B2B contract and license manufacturing of pharmaceutical products using the group's production facilities, offered to pharmaceutical partners.
  • Private Label (СТМ) Production for Pharmacy Chains Private label (СТМ) manufacturing projects implemented for retail pharmacy chains, enabling pharmacy networks to offer their own branded pharmaceutical preparations produced by Velpharm Group.
  • Velpharm-M Manufacturing Plant (Zelenograd) Newly opened pharmaceutical production plant 'Велфарм•М' (Velpharm-M) operating as the group's manufacturing subsidiary for the production of medicinal products.

Companies that use Bright Way Group

Customer profile

Segments3 records

Ideal customer profiles3 records

Bright Way Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Bright Way Group partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Pharmacy Chains (Аптечные сети)coreChannel Partner/ Reseller/ DistributorVelpharm Group implements private label (СТМ) projects for pharmacy chains, offering contract manufacturing and licensing production services. This enables pharmacy networks to offer their own branded pharmaceutical products manufactured by Velpharm.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Bright Way Group competitors and assessment

Company assessment

Direct peers

  • R-Pharm: Major Russian pharmaceutical manufacturer with branded generics, hospital, and contract manufacturing operations. Directly comparable to Velpharm in product category, B2B channels, and alignment with state domestic production policies.
  • Pharmasyntez: Russian finished-dose pharmaceutical manufacturer serving pharmacy chains and hospitals with a broad generic portfolio. Directly comparable to Velpharm's manufacturing model and domestic-market focus.
  • Biocad: Russian biopharmaceutical company producing both biologics and small-molecule generics with significant government backing. Comparable to Velpharm as a domestic manufacturer aligned with Russian pharmaceutical sovereignty goals.
  • GEROPHARM: Russian pharmaceutical company producing finished-dose generics and biologics with strong domestic market presence. Comparable to Velpharm as a domestic finished-dose manufacturer with government-aligned priorities.
  • Valenta Pharm: Russian pharmaceutical manufacturer with a broad branded generic and OTC portfolio sold primarily through pharmacy chains. Directly comparable to Velpharm in target customer base and finished-dose offering.
  • Pharmstandard (Фармстандарт): One of Russia's largest pharmaceutical manufacturers producing branded and generic preparations for primary care and hospital use. Directly comparable to Velpharm as a domestic finished-dose manufacturer targeting the same pharmacy chains and state-aligned import substitution agenda.
  • Obnovlenie (Renewal): Russian generic pharmaceutical manufacturer with a large SKU catalog distributed via pharmacy chains. Directly comparable to Velpharm in product type, scale, and reliance on the domestic pharmacy retail channel.
  • Polysan: Russian pharmaceutical manufacturer of branded generics and original products sold through pharmacy chains. Directly comparable to Velpharm in product category and B2B pharmacy channel.

Broad incumbents

  • KRKA: European generic pharmaceutical manufacturer with strong Eastern European and CIS market presence. Comparable to Velpharm in generic finished-dose manufacturing and in competing for CIS/Russian pharmacy chain demand.
  • Teva Pharmaceutical Industries: Global leader in generic pharmaceuticals with broad finished-dose manufacturing capabilities. Comparable to Velpharm at a category level (generic finished-dose manufacturing), though operating at vastly greater scale and global geography.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Bright Way Group social profiles

Digital presence

Bright Way Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bright Way Group leadership team

Management profile

Number of profiles

Bright Way Group subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

Bright Way Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bright Way Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bright Way Group

What does Bright Way Group do?

Velpharm Group is a Russian pharmaceutical manufacturing company that produces modern, high-quality, and affordable medicinal products, including essential medicines, with a portfolio of 12+ marketed preparations, 23+ vital essential medicines, 43+ preparations in registration, and 27+ under development. Beyond its own branded pharmaceutical production, the group offers contract manufacturing, licensing production, and private label (СТМ) projects for pharmacy chains, operating production facilities in Kurgan and at the newly opened Velpharm-M plant.

Is Bright Way Group a public or private company?

Bright Way Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Bright Way Group founded?

Bright Way Group was founded in -1. It employs 11 to 50 people.

Where is Bright Way Group based?

Bright Way Group is headquartered in Moscow, Russia, in the Europe region.

How does Bright Way Group make money?

One revenue line is on record: pharmaceutical Drug Sales.

Who are Bright Way Group's main competitors?

Direct peers on record are R-Pharm, Pharmasyntez, Biocad, GEROPHARM, Valenta Pharm, Pharmstandard (Фармстандарт), Obnovlenie (Renewal) and Polysan. Broad incumbents are KRKA and Teva Pharmaceutical Industries.

Does Bright Way Group have an API?

No public API is recorded for Bright Way Group.

What industry is Bright Way Group in?

Bright Way Group's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIAAAA, Primary Care & General Medicine Pharmaceuticals, with a secondary code of HLAGAHAL, GMP Scale-Up, Tech Transfer & Process Validation (PPQ). Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales